According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

Background Non-alcoholic fatty liver disease (NAFLD) is an emerging disease and a
leading cause of chronic liver disease. The prevalence in the general population is …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities
associated with overweight and metabolic syndrome (MetS). Importantly, NAFLD is one of its …

Nonalcoholic fatty liver disease (NAFLD), the most common of chronic liver disease in
Western Country, is closely related to insulin resistance and oxidative stress and includes a …

Considerable information is currently available from neuroimaging, pathological, and
population-based prospective studies showing that vascular risk factors are independently …

Adipocytokines are hormonally active molecules that are believed to play a key role in the
regulation of crucial biological processes in the human body. Numerous experimental …

Cardiovascular disease (CVD) is the leading cause of death in Western societies and
accounts for up to a third of all deaths worldwide. In comparison to the Northern European or …

We review the role of liver ultrasonography (US) and related techniques as non-invasive
tools in predicting metabolic derangements, liver histology, portal hypertension and …

The endothelium, which constitutes the inner layer of blood vessels and lymphatic
structures, plays an important role in various physiological functions. Alterations in structure …

Background Psoriasis is associated with higher incidence of atherosclerotic comorbidities.
Sustained arterial wall inflammation mediated by common cytokines of psoriasis and …